TLC BioSciences Corp. (TPEX:7924)

Taiwan · Delayed Price · Currency is TWD

438.50

-43.00 (-8.93%)

At close: Sep 24, 2026

TLC BioSciences Financials Overview

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Revenue	78.44	89.44	189.17
Revenue Growth	-	-52.72%	-
Gross Profit	48.62	73.93	126.25
Operating Income	-1,720	-639.05	-888.62
Net Income	-1,821	-653.25	-2,186
Earnings Per Share	-18.95	-7.84	-28.50
EPS Growth	-	-	-

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Cash & Investments	1,575	694.74	1,383
Total Debt	816.73	955.97	1,319
Net Cash (Debt)	758.48	-261.23	63.44
Net Cash Growth	-	-	-
Net Cash Per Share	7.89	-3.14	0.83

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Operating Cash Flow	-877.45	-347.17	-859.8
Capital Expenditures	-85.03	-117.83	-67.02
Free Cash Flow	-962.49	-464.99	-926.82
Free Cash Flow Growth	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Gross Margin	61.99%	82.66%	66.74%
Operating Margin	-2192.34%	-714.51%	-469.76%
Pretax Margin	-2315.16%	-725.24%	-1168.24%
Profit Margin	-2321.10%	-730.39%	-1155.44%
FCF Margin	-1227.05%	-519.91%	-489.95%